Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Fenofibric Acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

95 API Suppliers, 25 USDMF, 16 CEP/COS, 3 JDMF, 14 EU WC, 28 KDMF, 17 NDC API, 46 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

36 Drugs in Development

36 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

322 FDF Dossiers, 131 FDA Orange Book, 73 Europe, 12 Canada, 34 Australia, 3 South Africa, 69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 160MG, CAPSULE;ORAL - 150MG, CAPSULE;ORAL - 50MG, TABLET;ORAL - 145MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 48MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 130MG, CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 43MG, CAPSULE;ORAL - 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 105MG, TABLET;ORAL - 35MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 14 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Kewpie Corporation, 14 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 3 Kirsch Pharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 2 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 2 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 3 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 31 Roquette, 15 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 53 Solubilizers, 52 Thickeners and Stabilizers, 51 Coating Systems & Additives, 49 Direct Compression, 48 Disintegrants & Superdisintegrants, 40 Granulation, 31 Controlled & Modified Release, 31 Taste Masking, 30 Topical, 26 Lubricants & Glidants, 23 Parenteral, 22 Chewable & Orodispersible Aids, 22 Film Formers & Plasticizers, 18 Emulsifying Agents, 16 Co-Processed Excipients, 11 Rheology Modifiers, 10 API Stability Enhancers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 64 News #PharmaBuzz

GLOBAL SALES INFORMATION

61 US Medicaid Prescriptions, 39 Regulatory FDF Prices

MARKET PLACE

26 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 10 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 9 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
29/11/2025	IOL Chemicals and Pharmaceuticals	India	IOL CHEMICALS AND PHARMACEUTICALS LTD	36535	FENOFIBRATE USP	2022-01-05	Active	II	Complete	2024-02-05	2023-12-22
29/11/2025	Seqens	France	WAVELENGTH ENTERPRISES LTD	11194	FENOFIBRATE	1994-11-09	Active	II	N/A

Fenofibric Acid

Fenofibric Acid

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

95 API Suppliers

25 USDMF

16 CEP/COS

3 JDMF

14 EU WC

28 KDMF

17 NDC API

46 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

36 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

322 FDF Dossiers

131 FDA Orange Book

73 Europe

12 Canada

34 Australia

3 South Africa

69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 160MG

CAPSULE;ORAL - 150MG

CAPSULE;ORAL - 50MG

TABLET;ORAL - 145MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 48MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 130MG

CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 43MG

CAPSULE;ORAL - 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 105MG

TABLET;ORAL - 35MG

RELATED EXCIPIENT COMPANIES

1 Minakem

1 Evonik

2 Rochem International Inc

20 SPI Pharma

14 DKSH

1 PMC Isochem

1 Pharm-RX Chemical

8 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

2 Kewpie Corporation

14 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

3 Kirsch Pharma

4 ACG Worldwide

7 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

35 BASF

1 Bioplus Life Sciences

1 CD Formulation

2 Clariant

14 Corel Pharma Chem

7 DFE Pharma

1 Doshion Polyscience

2 Esteem Industries

2 Finar

14 Gangwal Chemicals

5 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

3 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

TABLET;ORAL - 145MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 48MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 90MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons